Molecular epidemiology of Mycobacterium tuberculosis in Nepal. (Record no. 1766)

MARC details
000 -LEADER
fixed length control field 04186nam a22002297a 4500
003 - CONTROL NUMBER IDENTIFIER
control field OSt
005 - DATE AND TIME OF LATEST TRANSACTION
control field 20220906184630.0
008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION
fixed length control field 130806b xxu||||| |||| 00| 0 eng d
060 ## - NATIONAL LIBRARY OF MEDICINE CALL NUMBER
Classification number THS-00327
100 ## - MAIN ENTRY--PERSONAL NAME
Personal name Malla, Bijaya.
9 (RLIN) 1925
245 ## - TITLE STATEMENT
Title Molecular epidemiology of Mycobacterium tuberculosis in Nepal.
260 ## - PUBLICATION, DISTRIBUTION, ETC.
Date of publication, distribution, etc. c2013.
300 ## - PHYSICAL DESCRIPTION
Extent ix, 143p. :
500 ## - GENERAL NOTE
General note Thesis Report.
520 ## - SUMMARY, ETC.
Summary, etc. SUMMARY: Tuberculosis (TB) is a global health problem. One reason of conducting molecular epidemiology studies is to understand the uneven distribution of the disease in different parts of the world. The global population structure of MTBC can be studied by genotyping strains from different geographic regions, which describes the evolutionary relatedness of MTBC. The choice of appropriate genetic tools is fundamental that can elucidate local as well as global spread of disease. Genetic markers like large sequence polymorphisms (LSPs) and single nucleotide polymorphisms (SNPs) have been used to construct phylogenies of MTBC lineages that are informative for understanding the global distribution of MTBC. Additionally, markers such as direct repeats can differentiate strains within smaller geographical settings or cohort of patients. Studies have shown that the lineages diversity itself could be associated with differences in the pathogenesis and epidemiology of TB. Most importantly, the emergence of drug resistance, which results mostly among treatment failures, is a serious threat to TB control programs. Our aim was to use those markers to explore the phylogenetic diversity and distribution of MTBC in Nepal and compare it to the global phylogeography of MTBC. Furthermore, to identify the mutational hotspots conferring drug resistance. Understanding the molecular mechanisms of drug resistance will allow us to develop rapid molecular drug resistance detection tools and management of TB cases with improved and more rational drug therapies. We used SNPs based genotyping tool for 506 M. tuberculosis strains from Nepal. This revealed four major lineages of MTBC. This allowed us to map the MTBC structure in Nepal compared to the global diversity. Additionally, the use of spoligotyping and MIRU-VNTR (used for XDR strains only) provided data within particular geographical settings and within human populations. A total of 69 different spoligotypes with unique SIT numbers were identified. We found Beijing and Central Asian Strain (CAS) family as the predominant genotypes as was expected owing to geo-position of Nepal in Asia. Molecular analysis of drug resistance for most common anti-TB drugs (i.e. isoniazid, rifampicin) from our sample set confirmed that the polymorphisms were more or less similar as previously documented globally, although we found some additional non-synonymous mutations which need validation. In general, our findings showed that the rapid molecular tools currently developed will detect most of the drug resistance isolates in Nepal. Among drug resistance strains, the katG S315T was proportionally more represented by multi-drug resistance strains. However, the patterns of rpoB mutation were unrelated to multi-drug resistance or MTBC genotypes. By performing 24 MIRU-VNTR loci plus additional 4 hyper variable region intended to use for Beijing spoligotypes, we provide evidence of primary transmission of XDR strains. On the other hand, the aim was to identify risk factors, risk groups, and co-morbidities that may relate to the susceptibility to TB. The number of male patients constituted two-third of the total sample population and most of them were at the age of 15-24 years. However, female TB patients in Nepal seem to be associated with "virulent" strains of TB (Beijing genotype) and drug resistance. We identified four XDR cases; the younger age (median age 21 yrs.) of XDR-TB is a serious matter that requires immediate attention from NTP, Nepal.
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Molecular epidemiology.
9 (RLIN) 1996
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Mycobacterium.
9 (RLIN) 1997
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Tuberculosis.
9 (RLIN) 891
650 ## - SUBJECT ADDED ENTRY--TOPICAL TERM
Topical term or geographic name entry element Nepal.
9 (RLIN) 362
856 ## - ELECTRONIC LOCATION AND ACCESS
Uniform Resource Identifier <a href="http://nhrc.gov.np/contact/">http://nhrc.gov.np/contact/</a>
Link text Visit NHRC Library
942 ## - ADDED ENTRY ELEMENTS (KOHA)
Source of classification or shelving scheme National Library of Medicine
Koha item type Thesis Report
Holdings
Withdrawn status Lost status Source of classification or shelving scheme Damaged status Not for loan Home library Current library Shelving location Date acquired Inventory number Total Checkouts Full call number Barcode Date last seen Price effective from Koha item type
    National Library of Medicine     Nepal Health Research Council Nepal Health Research Council Reference 08/06/2013 327   THS00327/MAL/2013 THS-00327 08/06/2013 08/06/2013 Thesis Report

Nepal Health Research Council © 2024.

Ramshah Path, Kathmandu, Nepal, P.O.Box 7626

Web: https://nhrc.gov.np/ | Email : nhrc@nhrc.gov.np | Phone : 977-1-4254220

Maintained by Chandra Bhushan Yadav, Library & Information Officer, NHRC